Betad-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceuticalcompositions containing it

Betad-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceuticalcompositions containing it

Beta d-crystalline form of ivabradine hydrochloride (I), which is characterized by powder X-ray diffraction diagram measured using a PANalytical X'Pert Pro diffractometer together with an X'Celerator detector and expressed in terms of ray position (Bragg's angle 2 theta, expressed in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HORVATH STEPHANIE, DAMIEN GERARD, AUGUSTE MARIE-NOELLE
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Beta d-crystalline form of ivabradine hydrochloride (I), which is characterized by powder X-ray diffraction diagram measured using a PANalytical X'Pert Pro diffractometer together with an X'Celerator detector and expressed in terms of ray position (Bragg's angle 2 theta, expressed in degrees), ray height (expressed in counts), ray area (expressed in countsx degrees), full width at half maximum (FWHM, expressed in degrees) and interplanar distance d (expressed in Å ), according to the given specification, is new. An independent claim is included for the preparation of (I). [Image] ACTIVITY : Antiarrhythmic; Cardiant; Vasotropic; Antianginal. MECHANISM OF ACTION : None given.